Literature DB >> 16586031

A short estrogen-responsive N-terminal galanin homologue found in rat brain and gut with antiserum raised against rat galanin(1-16).

Susanne Hilke1, Tomas Hökfelt, Elvar Theodorsson.   

Abstract

Galanin-like peptide (GALP) is currently the only known galanin(1-29) homologue. However, three different galanin receptors, of which GalR3 exhibits comparatively low affinity for galanin(1-29), and molecular heterogeneity of immunoreactive galanin are arguments for presence of other endogenous galanin homologues. Since antibodies recognize three-dimensional structures of 3-5 amino acids in a peptide, we raised antibodies in rabbits against galanin(1-16) conjugated to bovine serum albumin, looking for the presence of endogenous N-terminal galanin homologues in rat tissues. The antiserum selected had 7,830 times higher avidity for galanin(1-16) compared to galanin(1-29). A single immunoreactive component with a Stokes radius of about 8 amino acids was found. Immunohistochemistry strongly suggested that this immunoreactivity is localised in the same neurons as galanin(1-29). Furthermore, its concentration was increased in response to estrogen treatment in the same brain regions as galanin(1-29), although not as rapidly. The present results indicate the presence of a novel endogenous N-terminal galanin homologue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16586031     DOI: 10.1007/s11064-005-9007-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  54 in total

Review 1.  Chemistry and molecular biology of galanin receptor ligands.

Authors:  U Langel; T Bartfai
Journal:  Ann N Y Acad Sci       Date:  1998-12-21       Impact factor: 5.691

2.  Linear and cyclic N-terminal galanin fragments and analogs as ligands at the hypothalamic galanin receptor.

Authors:  T Land; U Langel; M Löw; M Berthold; A Undén; T Bartfai
Journal:  Int J Pept Protein Res       Date:  1991-09

Review 3.  The neuropeptide story. Geoffrey Harris Lecture, Budapest, Hungary, July 1994.

Authors:  D de Wied
Journal:  Front Neuroendocrinol       Date:  1997-01       Impact factor: 8.606

4.  Localization of preprogalanin messenger RNA in rat brain: identification of transcripts in a subpopulation of cerebellar Purkinje cells.

Authors:  M C Ryan; A L Gundlach
Journal:  Neuroscience       Date:  1996-02       Impact factor: 3.590

5.  Distribution of galanin immunoreactivity in the genitourinary tract of man and rat.

Authors:  F E Bauer; N D Christofides; G W Hacker; M A Blank; J M Polak; S R Bloom
Journal:  Peptides       Date:  1986 Jan-Feb       Impact factor: 3.750

6.  Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylenediamine.

Authors:  J L Platt; A F Michael
Journal:  J Histochem Cytochem       Date:  1983-06       Impact factor: 2.479

7.  Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors.

Authors:  Z Q Xu; T J Shi; T Hökfelt
Journal:  J Comp Neurol       Date:  1998-03-09       Impact factor: 3.215

8.  Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus.

Authors:  T Ohtaki; S Kumano; Y Ishibashi; K Ogi; H Matsui; M Harada; C Kitada; T Kurokawa; H Onda; M Fujino
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

9.  Distribution of galanin immunoreactivity in the central nervous system and the responses of galanin-containing neuronal pathways to injury.

Authors:  J L Ch'ng; N D Christofides; P Anand; S J Gibson; Y S Allen; H C Su; K Tatemoto; J F Morrison; J M Polak; S R Bloom
Journal:  Neuroscience       Date:  1985-10       Impact factor: 3.590

10.  Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS.

Authors:  T Melander; T Hökfelt; A Rökaeus; A C Cuello; W H Oertel; A Verhofstad; M Goldstein
Journal:  J Neurosci       Date:  1986-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.